Össur CEO believes in US growth
Prosthetics company Össur can look back on a third quarter that offered a 28 % improvement of the company’s bottom line. The US market remains a challenge, but the company’s CEO believes market shares can be won.
by Benjamin Werner Christensen
The US market has been a huge challenge for Össur, the Icelandic manufacturer of orthopedic devices, for some time. In the recent third quarter there was, however, a slight rise in sales of 1 % in spite of the difficulties that American reimbursement rules led to. And things could become even better, anticipates the CEO of the Icelandic company, Jon Sigurdsson.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Össur in triple-digit-million acquisition
For abonnenter
”We will not buy our way out of the problems”
For abonnenter
